首页 | 本学科首页   官方微博 | 高级检索  
检索        

幽门螺杆菌重组粘附素的安全性、免疫原性和生物学活性的体外评价
引用本文:白杨,陈烨,林焕建,王继德,唱韶红,周殿元,张亚历.幽门螺杆菌重组粘附素的安全性、免疫原性和生物学活性的体外评价[J].第一军医大学学报,2003,23(9):882-884.
作者姓名:白杨  陈烨  林焕建  王继德  唱韶红  周殿元  张亚历
作者单位:[1]第一军医大学南方医院全军消化病研究所,广东,广州510515 [2]军事医学科学院生物工程研究所,北京100071,广东,广州510515
摘    要:目的 通过体外实验确定重组粘附素(rBabA)的安全性、免疫原性及粘附作用,探讨rBabA在幽门螺杆菌(Hp)疫苗应用中的可行性。方法 二苯胺法测定rBabA致T细胞凋亡率.ELISA法测定Hp感染者血清中抗rBabA抗体.MTT法测定T细胞对rBabA的增殖反应.光镜计数法研究rBabA对Hp与胃癌细胞粘附的影响。结果 体外安全性实验表明rBabA无明显致BabA抗体阴性者T细胞凋亡的作用.而且可刺激rBabA抗体阳性者T细胞的增殖;ELISA法共检测了38份Hp感染患者血清,rBabA抗体阳性率为18.4%。rBabA能部分阻断Hp与胃癌细胞系的粘附。结论 研究表明rBabA是安全的、具有免疫原性的。Hp菌体成分.既可以刺激体液免疫,又能够提高细胞免疫,有望成为针对BabA2基因阳性。Hp菌株疫苗研制中一种有效的新抗原。

关 键 词:幽门螺杆菌重组粘附素  安全性  免疫原性  生物学  疫苗  研制

In vitro evaluation of the safety and biological activity of recombinant Helicobacter pylori blood group antigen-binding adhesin]
Yang Bai,Ye Chen,Huan-jian Lin,Ji-de Wang,Shao-hong Chang,Dian-yuan Zhou,Ya-li Zhang.In vitro evaluation of the safety and biological activity of recombinant Helicobacter pylori blood group antigen-binding adhesin][J].Journal of First Military Medical University,2003,23(9):882-884.
Authors:Yang Bai  Ye Chen  Huan-jian Lin  Ji-de Wang  Shao-hong Chang  Dian-yuan Zhou  Ya-li Zhang
Institution:Institute for Digestive Diseases of PLA, First Military Medical University, Guangzhou 510515, China.
Abstract:OBJECTIVE: To evaluate the safety and biological activity of recombinant Helicobacter pylori (Hp) blood group antigen- binding adhesin (rBabA ) in vitro so as to investigate the feasibility of using rBabA as a Hp vaccine. METHODS: ELISA was used to measure rBabA-specific antibody in the serum of Hp-infected patients, and the proliferation of T lymphocytes in response to rBabA was examined by MTT assay. T cell apoptosis induced by rBabA was detected by diphenylamine assay. The effect of rBabA on Hp binding into human gastric carcinoma cell line(MGC-803) was determined by light microscopy. RESULTS: rBabA did not induce T cell apoptosis in BabA antibody- negative patients and was capable of stimulating T cell proliferation in rBabA antibody-positive patients. In the serum samples from 38 Hp-infected patients, the rBabA antibody positivity rate was 18.4%. rBabA could partially inhibit the binding of Hp to gastric epithelial cells. Under light microscope, the adhesion of Hp to MGC-803 was significantly inhibited by rBabA in comparison with negative control with PBS pretreatment. CONCLUSION: rBabA proves to be a safe and immunogenic bacterial component of Hp, which stimulates humoral and cellular immunity and can be a hopeful antigen targeting at BabA2 gene-positive Hp strain for the development of Hp vaccine.
Keywords:
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号